line
371 results
1 - 100- nilotinib
- erlotinib
- ferric pyrophosphate citrate
- bexarotene
- defibrotide
- sodium sulfate/potassium sulfate/magnesium sulfate
- prabotulinumtoxina
- imatinib
- sodium phosphate
- letrozole
- thiothixene
- nivolumab
- mogamulizumab
- dacarbazine
- enoxacin
- thioridazine
- albiglutide
- onabotulinumtoxinA
- topotecan
- abobotulinumtoxinA
- tazarotene
- cetuximab
- necitumumab
- fospropofol
- incobotulinumtoxinA
- isoniazid
- molindone
- avelumab
- posaconazole
- oritavancin
- afatinib
- bezlotoxumab
- olaparib
- dasatinib
- sugammadex
- ipilimumab
- axitinib
- loxapine
- trifluoperazine
- clevidipine
- rasburicase
- teclistamab
- irinotecan
- lindane
- pemoline
- muromonab-CD3
- vestronidase alfa-vjbk
- bevacizumab
- larotrectinib
- chlorproMAZINE
- ceritinib
- copanlisib
- lorlatinib
- basiliximab
- pembrolizumab
- dacomitinib
- erdafitinib
- pegaspargase
- ustekinumab
- durvalumab
- atezolizumab
- botulism immune globulin
- vigabatrin
- turoctocog alfa
- trabectedin
- daratumumab/hyaluronidase
- pretomanid
- lecanemab
- ibritumomab
- gefitinib
- goserelin
- quazepam
- etoposide phosphate
- duvelisib
- sodium phenylacetate/sodium benzoate
- reteplase
- eptinezumab
- brexanolone
- isatuximab
- dinutuximab
- darbepoetin
- entrectinib
- reslizumab
- olaratumab
- eteplirsen
- cemiplimab
- polyethylene glycol/electrolyte